US 11,945,819 B1
Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents
Katharigatta N. Venugopala, Al-Ahsa (SA); Pran Kishore Deb, Al-Ahsa (SA); Pramod Patil, Al-Ahsa (SA); Osama I. Alwassil, Al-Ahsa (SA); Mohamed A. Morsy, Al-Ahsa (SA); Bandar Aldhubiab, Al-Ahsa (SA); Vijaykumar Uppar, Al-Ahsa (SA); Mahmoud Kandeel, Al-Ahsa (SA); Praveen B. Managutti, Al-Ahsa (SA); and Basavaraj Padmashali, Al-Ahsa (SA)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Sep. 21, 2023, as Appl. No. 18/371,126.
Int. Cl. A61K 31/4353 (2006.01); A61P 29/00 (2006.01); C07D 471/04 (2006.01); C07D 471/16 (2006.01)
CPC C07D 471/04 (2013.01) [A61P 29/00 (2018.01); C07B 2200/13 (2013.01)] 17 Claims
 
1. A compound having the formula I:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof,
wherein:
R is halogen.
 
9. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of the compound of claim 1, or a pharmaceutically acceptable salt thereof.